Jennison Associates LLC Kymera Therapeutics, Inc. Transaction History

Jennison Associates LLC

$141 Billion
Q1 2025

A detailed history of Jennison Associates LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 552,286 shares of KYMR stock, worth $25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

552,286

Previous 716,933 22.97%

Holding current value

$25 Million

Previous $28.8 Million 47.59%

% of portfolio

0.01%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	SELL	$27.37 - $44.36 $4.51 Million - $7.3 Million	-164,647 Reduced 22.97%	552,286 $15.1 Million
Q4 2024 Jan 24, 2025	SELL	$39.06 - $51.84 $3.15 Million - $4.19 Million	-80,748 Reduced 10.12%	716,933 $28.8 Million
Q3 2024 Nov 08, 2024	BUY	$30.16 - $52.4 $11.1 Million - $19.3 Million	368,394 Added 85.82%	797,681 $37.8 Million
Q2 2024 Aug 05, 2024	BUY	$29.85 - $39.42 $100,504 - $132,727	3,367 Added 0.79%	429,287 $12.8 Million
Q1 2024 May 02, 2024	BUY	$22.9 - $43.57 $9.75 Million - $18.6 Million	425,920 New	425,920 $17.1 Million
Q1 2022 May 11, 2022	SELL	$35.3 - $64.68 $6.44 Million - $11.8 Million	-182,326 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$49.91 - $65.56 $112,547 - $147,837	-2,255 Reduced 1.22%	182,326 $11.6 Million
Q3 2021 Nov 09, 2021	SELL	$47.8 - $66.66 $101,336 - $141,319	-2,120 Reduced 1.14%	184,581 $10.8 Million
Q1 2021 May 11, 2021	BUY	$35.64 - $85.46 $4.18 Million - $10 Million	117,346 Added 169.2%	186,701 $7.26 Million
Q4 2020 Feb 05, 2021	SELL	$28.07 - $87.83 $18,778 - $58,758	-669 Reduced 0.96%	69,355 $4.3 Million
Q3 2020 Nov 04, 2020	BUY	$26.1 - $33.28 $1.83 Million - $2.33 Million	70,024 New	70,024 $2.26 Million

Others Institutions Holding KYMR

# of Institutions

178

Shares Held

67.4M

Call Options Held

223K

Put Options Held

241K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.47B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Kymera Therapeutics, Inc. Transaction History